Session 2: Update on the Pharmacotherapy of Sleeping and Anxiety Disorders

Date: 2/15/2012 Check-In and Breakfast:
 7:00 am - 7:30 am
Educational Session: 7:30 am - 1:00 pm
Edward Fisher, Ph.D.,R.Ph. Professor of Pharmacology and Toxicology and Associate Dean for Academic Affairs University of Hawaii at Hilo College of Pharmacy , Live CME Instructor for University Learning Systems

Edward Fisher, Ph.D., R.Ph., Professor of Pharmacology and Toxicology, Associate Dean for  Academic Affairs, Director of the MS in Psychopharmacology Program, College of Pharmacy, University of Hawaii at Hilo. Disclosure: Dr. Fisher  has no financial arrangements with any corporate organization that might have an interest in the subject being presented.

At the conclusion of this program, the participant should be able to:

 

  •  Describe the distinguishing factors that are associated with various types of sleeping and anxiety disorders;
  • Recall the diagnostic criteria used for sleeping and anxiety disorders;
  • Explain the current theories on the etiology of sleeping and anxiety disorders;
  • Describe the various clinical symptoms associated with the disease states discussed;
  • Discuss the prognosis and epidemiology of the disease states discussed;
  • Implement appropriate pharmacotherapy of the disease states discussed;
  • Compare and contrast the efficacy of the drugs used for each disorder discussed;
  • Recall the pharmacological properties of the drugs used to treat these disorders;
  • List the adverse effects associated with the drugs commonly used to treat these disorders.